- Home
- OTLY vs TSVT Comparison
OTLY vs TSVT Comparison
Compare OTLY & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLY
- TSVT
- Stock Information
- Founded
- OTLY 1994
- TSVT 2021
- Country
- OTLY Sweden
- TSVT United States
- Employees
- OTLY N/A
- TSVT N/A
- Industry
- OTLY Packaged Foods
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- OTLY Consumer Staples
- TSVT Health Care
- Exchange
- OTLY Nasdaq
- TSVT Nasdaq
- Market Cap
- OTLY 256.5M
- TSVT 258.9M
- IPO Year
- OTLY 2021
- TSVT N/A
- Fundamental
- Price
- OTLY $9.27
- TSVT $4.98
- Analyst Decision
- OTLY Buy
- TSVT Buy
- Analyst Count
- OTLY 4
- TSVT 4
- Target Price
- OTLY $19.75
- TSVT $6.50
- AVG Volume (30 Days)
- OTLY 108.9K
- TSVT 1.1M
- Earning Date
- OTLY 04-30-2025
- TSVT 05-07-2025
- Dividend Yield
- OTLY N/A
- TSVT N/A
- EPS Growth
- OTLY N/A
- TSVT N/A
- EPS
- OTLY N/A
- TSVT N/A
- Revenue
- OTLY $823,666,000.00
- TSVT $37,862,000.00
- Revenue This Year
- OTLY $3.92
- TSVT $84.48
- Revenue Next Year
- OTLY $6.14
- TSVT $9.69
- P/E Ratio
- OTLY N/A
- TSVT N/A
- Revenue Growth
- OTLY 5.15
- TSVT N/A
- 52 Week Low
- OTLY $6.00
- TSVT $2.29
- 52 Week High
- OTLY $26.80
- TSVT $5.30
- Technical
- Relative Strength Index (RSI)
- OTLY 50.76
- TSVT 75.48
- Support Level
- OTLY $8.40
- TSVT $4.97
- Resistance Level
- OTLY $8.90
- TSVT $4.99
- Average True Range (ATR)
- OTLY 0.43
- TSVT 0.03
- MACD
- OTLY 0.04
- TSVT -0.06
- Stochastic Oscillator
- OTLY 76.79
- TSVT 90.91
About OTLY Oatly Group AB
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, and Icecreams, among others. It caters to Sweden, Germany, the United Kingdom, Netherlands, North America, Finland, and Other markets. The company generates revenue from the EMEA, Americas, and Asia regions, with the majority of revenue generated from the EMEA region.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.